A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Sanjay Goel, Umang Swami, Kirushna Kumar, Christian Dittrich, Larisa Reyderman, Minish Jain, Joseph Aisner, James Song, Daniel P. Petrylak

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds